A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2015

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions

HER2 Expressing Breast or Gastric/Stomach Cancers

Interventions

BIOLOGICAL

MEDI4276

MEDI4276 is an investigational product

Trial Locations (5)

Research Site, Charlotte

Research Site, Sarasota

Research Site, Nashville

Research Site, Indianapolis

Research Site, Stanford